Humana , along with much of the health insurance sector, is struggling with the prospect of smaller reimbursements from ...

It’s the latest in a string of lawsuits from health insurers scrambling to protect their prized quality scores and the money that ratings represent.

Humana has sued the Centers for Medicare and Medicaid Services over the results of the 2025 Medicare Advantage and Part D Star Ratings.

Humana, one the country’s largest Medicare Advantage organizations, is suing the Centers for Medicare & Medicaid Services ...

Humana (HUM) sues U.S. health agencies seeking to reverse a cut to crucial Medicare quality ratings, linked to billions of dollars in revenue, ...

Humana faces significant challenges with rising denial rates and customer disenrollment, leading to a sharp decline in stock ...

Humana Inc., has filed a lawsuit against CMS in response to a recent cut in crucial Medicare quality ratings. The lawsuit is an attempt to reverse the decision which has already hurt its stock value ...

Humana filed the suit on October 18 in the Northern District of Texas federal court, presided over by Judge Reed O'Connor.

The lawsuit argues that the Medicare program was “arbitrary and capricious” in how it calculated the metrics for Humana’s ...

Discussions over Cigna's possible purchase of Humana reportedly have resumed after the two health insurers failed to strike a ...

UnitedHealth, CVS and Humana used technology to increase MA prior authorization denials for post-acute services, boosting profits, according to a report from a Senate subcommittee.

周二，RBC Capital调整了Humana（纽约证券交易所代码：HUM）的股价目标，将其从之前的400美元下调至265美元。该公司维持了对这家医疗保健公司的"跑赢大市"评级。此次调整是在Humana上周在8-K文件中披露的基于初步Medicare Advantage（MA）表现数据的星级评级下降之后做出的。 RBC Capital引入了对Humana 2026年调整后每股收益（EPS）的预估， ...